A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever

Michael Ellis, Roos Bernsen, Hussein Ali-Zadeh, Jörgen Kristensen, Ulla Hedström, Lazaros Poughias, Mark Bresnik, Awad Al-Essa, David A. Stevens

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A safety and feasibility study comparing an intermittent high dose with a daily standard dose of liposomal amphotericin B for persistent neutropenic fever'. Together they form a unique fingerprint.

Medicine & Life Sciences